(Q39915996)

English

Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26982210%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26982210%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

Richard Donnelly

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26982210%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Jil Mamza

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26982210%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Rajnikant Mehta

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26982210%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Iskandar Idris

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26982210%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

language of work or name

0 references

publication date

16 March 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26982210%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Annals of Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26982210%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

48

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26982210%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26982210%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

224-234

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26982210%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Durability of oral hypoglycemic agents in drug naïve patients with type 2 diabetes: report from the Swedish National Diabetes Register (NDR).

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

A tutorial on propensity score estimation for multiple treatments using generalized boosted models

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

The multiple propensity score as control for bias in the comparison of more than two treatment arms: an introduction from a case study in mental health.

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores.

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy.

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Drug-Induced Diabetes Mellitus: Evidence for Statins and Other Drugs Affecting Glucose Metabolism

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2016.1157263

21 January 2018

Identifiers

10.3109/07853890.2016.1157263

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26982210%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26982210%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39915996&oldid=1474479291"